Biomedicines (Sep 2023)

Gut Microbiota Alteration and Its Modulation with Probiotics in Celiac Disease

  • Angela Saviano,
  • Carmine Petruzziello,
  • Mattia Brigida,
  • Maria Rita Morabito Loprete,
  • Gabriele Savioli,
  • Alessio Migneco,
  • Veronica Ojetti

DOI
https://doi.org/10.3390/biomedicines11102638
Journal volume & issue
Vol. 11, no. 10
p. 2638

Abstract

Read online

Celiac disease (CD) is a chronic inflammation of the small intestine triggered by gluten ingestion in genetically predisposed people. Recent literature studies highlight the possible role of the gut microbiota in the pathogenesis of this disease. The gut microbiota is a complex community of microorganisms that can interact with the innate and adaptative immune systems. A condition of dysbiosis, which refers to an alteration in the composition and function of the human gut microbiota, can lead to a dysregulated immune response. This condition may contribute to triggering gluten intolerance, favoring the development and/or progression of CD in genetically susceptible patients. Interestingly, studies on children and adults with CD showed a different microbiome profile in fecal samples, with a different degree of “activity” for the disease. From this point of view, our review aimed to collect and discuss modern evidence about the alteration of the gut microbiota and its modulation with probiotics, with possible future indications in the management of patients affected by CD.

Keywords